Your cognitive future, in your hands today

Prevent brain deterioration before it becomes irreversible

Do you have a family history of Alzheimer's? Do you notice frequent forgetfulness, brain fog, or mood swings? Thisinnovative genetic analysis identifies your hereditary risk of developingAlzheimer'sdisease and other neurodegenerative disorders by analyzing 18 key genes. Knowing early allows you to take action now, with personalized prevention.

Using a blood sample and advanced genomic technology (RT-PCR with TaqMan probes in OpenArray), the Alzheimer's Genetic Panel detects variants in genes involved in:

•  Production and accumulation of beta-amyloid: APOE, ABCA7, PSEN1, PICALM, CPZ
•  Inflammation and immune response: CR1, TNF, NOS3
•  Synaptic degeneration and neuronal death: MAPT, DISC1, LHFPL6, PRNP, BIN1
•  Lipid and vascular processing: ACE, CLU, MS4A6A/MS4A4E

The relative risk is also determined based on the number and type of polymorphisms found, including the presence of the APOE*E4 allele, the main genetic factor associated with late-onset Alzheimer's disease.

More information at:analisis@biosalud.org

Key benefits compared to other analyses

•  Includes the most relevant genes validated by international studies (GWAS).
•  Calculate your personalized relative risk, differentiating between low, medium, or high risk.
•  Technology of high precision and reliability clinic.
•  Ideal for designing preventive lifestyle plans, diet, nutraceuticals, and neurofunctional control.
•  Focused on sporadic Alzheimer's disease (more than 95% of cases), not only in rare hereditary forms.